诊断学理论与实践 ›› 2018, Vol. 17 ›› Issue (05): 601-605.doi: 10.16150/j.1671-2870.2018.05.023
张梦雪, 王小钦
收稿日期:
2018-03-26
出版日期:
2018-10-25
发布日期:
2018-10-25
通讯作者:
王小钦 E-mail: wangxiaoqin@shmu.edu.cn
基金资助:
Received:
2018-03-26
Online:
2018-10-25
Published:
2018-10-25
中图分类号:
张梦雪, 王小钦. 铁稳态失调相关的炎症性贫血发病机制及诊断进展[J]. 诊断学理论与实践, 2018, 17(05): 601-605.
[1] Gangat N, Wolanskyj AP.Anemia of chronic disease[J]. Semin Hematol,2013,50(3):232-238. [2] Joosten E, Lioen P.Iron deficiency anemia and anemia of chronic disease in geriatric hospitalized patients: How frequent are comorbidities as an additional explanation for the anemia?[J]. Geriatr Gerontol Int,2015,15(8):931-935. [3] Ganz T, Nemeth E.Iron Balance and the Role of Hepcidin in Chronic Kidney Disease[J]. Semin Nephrol,2016, 36(2):87-93. [4] Nemeth E, Tuttle MS, Powelson J, et al.Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization[J]. Science,2004,306(5704):2090-2093. [5] McCranor BJ, Kim MJ, Cruz NM, et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells[J]. Blood Cells Mol Dis,2014,52(2-3):126-133. [6] van Rooijen E, Santhakumar K, Logister I, et al. A zebrafish model for VHL and hypoxia signaling[J]. Methods Cell Biol,2011,105:163-190. [7] Liu Q, Davidoff O, Niss K, et al.Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis[J]. J Clin Invest,2012,122(12):4635-4644. [8] Mastrogiannaki M, Matak P, Mathieu JR, et al.Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis[J]. Haematologica,2012,97(6):827-834. [9] Arndt S, Maegdefrau U, Dorn C, et al.Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression [10] Dinkla S, van Eijk LT, Fuchs B, et al. Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane[J]. BBA Clin,2016,5:186-192. [11] Mitlyng BL, Singh JA, Furne JK, et al.Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases[J]. Am J Hematol,2006,81(6):432-438. [12] Kautz L, Jung G, Du X, et al.Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia[J]. Blood,2015,126(17):2031-2037. [13] Kautz L, Jung G, Valore EV, et al.Identification of erythroferrone as an erythroid regulator of iron metabolism[J]. Nat Genet,2014,46(7):678-684. [14] Wang CY, Babitt JL.Hepcidin regulation in the anemia of inflammation[J]. Curr Opin Hematol,2016,23(3):189-197. [15] Vecchi C, Montosi G, Zhang K, et al.ER stress controls iron metabolism through induction of hepcidin[J]. Science,2009,325(5942):877-880. [16] Millonig G, Ganzleben I, Peccerella T, et al. Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3(STAT3)[J]. J Biol Chem.2012 Oct 26;287(44):37472-37482. [17] Constante M, Jiang W, Wang D, et al.Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation[J]. Am J Physiol Gastrointest Liver Physiol,2006,291(2):G229-G237. [18] Gardenghi S, Renaud TM, Meloni A, et al.Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus[J]. Blood,2014,123(8):1137-1145. [19] Guida C, Altamura S, Klein FA, et al.A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia[J]. Blood,2015,125(14):2265-2275. [20] Kanwar JR, Roy K, Patel Y, et al.Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions[J]. Molecules,2015,20(6):9703-9731. [21] 赵晋英, 周沛, 刘翠, 等. 血清铁调素含量在鉴别缺铁性贫血和慢性病贫血中的意义[J]. 广东医学,2010,31(23):3091-3093. [22] Pasricha SR, Atkinson SH, Armitage AE, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children[J]. Sci Transl Med,2014,6(235):235re3. [23] Nemeth E, Ganz T.Anemia of inflammation[J]. Hematol Oncol Clin North Am,2014,28(4):671-681. |
[1] | 杨慧, 李云璐, 杨康, 李世举, 何瑾. 进行性肌阵挛共济失调近亲家系全外显子测序漏诊原因分析与对策[J]. 诊断学理论与实践, 2022, 21(04): 456-461. |
[2] | 陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534. |
[3] | 汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298. |
[4] | 罗雅方, 徐倩玥, 余红. 尘螨在特应性皮炎中的致病机制及相关免疫治疗应用研究进展[J]. 诊断学理论与实践, 2021, 20(06): 592-595. |
[5] | 苏长青. 从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433. |
[6] | 章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(03): 229-232. |
[7] | 徐兆平, 王浩飞. ZNF692基因在肾透明细胞癌中的表达及其与患者预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 292-296. |
[8] | 余红, 王一飞, 陈佳, 陈洁, 李斌. 青蒿素及其衍生物在皮肤疾病中的作用机制研究及临床应用[J]. 诊断学理论与实践, 2019, 18(2): 233-236. |
[9] | 魏坚, 高平进, 韩卫青. α7烟碱型乙酰胆碱受体激动剂对TGF-β1介导的血管外膜成纤维细胞表型转化影响的体外研究[J]. 诊断学理论与实践, 2019, 18(1): 56-60. |
[10] | 房莹, 吴东, 常春康. 癌基因与抑癌基因在伯基特淋巴瘤发生发展中的研究进展[J]. 诊断学理论与实践, 2019, 18(06): 630-633. |
[11] | 徐婷婷, 张文. 感染与中性粒细胞胞质抗体相关性血管炎间相关性的研究进展[J]. 诊断学理论与实践, 2019, 18(06): 698-703. |
[12] | 刘海霞, 瞿介明. 肺部微生态及其与肺癌关系的研究进展[J]. 诊断学理论与实践, 2019, 18(05): 496-502. |
[13] | 蔡业冰, 任家俊, 郝风节, 叶枫, 杨宇尘, 龚笑勇, 马迪, 王俊青, 陈拥军. 人类假基因在以肝癌为主的肿瘤中的作用及研究进展[J]. 诊断学理论与实践, 2019, 18(05): 590-594. |
[14] | 周敏, 张秋蕊. 呼吸道、肠道微生物菌群对慢性阻塞性肺疾病的发病及治疗的影响[J]. 诊断学理论与实践, 2019, 18(03): 246-249. |
[15] | 时国朝, 黄春容. 呼吸道及肠道微生物菌群与支气管哮喘的发病及治疗[J]. 诊断学理论与实践, 2019, 18(03): 241-245. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||